119 related articles for article (PubMed ID: 12620079)
1. Systematic development of high affinity bis(ammonio)alkane-type allosteric enhancers of muscarinic ligand binding.
Muth M; Bender W; Scharfenstein O; Holzgrabe U; Balatkova E; Tränkle C; Mohr K
J Med Chem; 2003 Mar; 46(6):1031-40. PubMed ID: 12620079
[TBL] [Abstract][Full Text] [Related]
2. Elevation of ligand binding to muscarinic M(2) acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators.
Raasch A; Scharfenstein O; Tränkle C; Holzgrabe U; Mohr K
J Med Chem; 2002 Aug; 45(17):3809-12. PubMed ID: 12166953
[TBL] [Abstract][Full Text] [Related]
3. Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems.
Zlotos DP; Buller S; Stiefl N; Baumann K; Mohr K
J Med Chem; 2004 Jul; 47(14):3561-71. PubMed ID: 15214783
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agents.
Muth M; Sennwitz M; Mohr K; Holzgrabe U
J Med Chem; 2005 Mar; 48(6):2212-7. PubMed ID: 15771463
[TBL] [Abstract][Full Text] [Related]
5. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
6. Cooperative interactions at M2 muscarinic acetylcholine receptors: structure/activity relationships in stepwise shortened bispyridinium- and bis(ammonio)alkane-type allosteric modulators.
Gilsbach R; Grossmüller M; Alptüzün V; Erciyas E; Tränkle C; Holzgrabe U; Mohr K
Neurochem Res; 2003 Apr; 28(3-4):667-73. PubMed ID: 12675159
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic allosteric modulators: atypical structure-activity-relationships in bispyridinium-type compounds.
Sürig U; Gaal K; Kostenis E; Tränkle C; Mohr K; Holzgrabe U
Arch Pharm (Weinheim); 2006 Apr; 339(4):207-12. PubMed ID: 16572483
[TBL] [Abstract][Full Text] [Related]
8. Contribution of lateral substituents in symmetrical and non-symmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptors.
Staudt M; Tränkle C; Mohr K; Holzgrabe U
Arch Pharm (Weinheim); 2003 Aug; 336(8):385-9. PubMed ID: 14502759
[TBL] [Abstract][Full Text] [Related]
9. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
10. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
11. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
12. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
13. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
14. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
Avlani V; May LT; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
[TBL] [Abstract][Full Text] [Related]
15. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
Redka DS; Pisterzi LF; Wells JW
Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
[TBL] [Abstract][Full Text] [Related]
16. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
May LT; Lin Y; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
[TBL] [Abstract][Full Text] [Related]
17. Bisquaternary ligands of the common allosteric site of M2 acetylcholine receptors: search for the minimum essential distances between the pharmacophoric elements.
Nassif-Makki T; Tränkle C; Zlotos D; Bejeuhr G; Cambareri A; Pfletschinger C; Kostenis E; Mohr K; Holzgrabe U
J Med Chem; 1999 Mar; 42(5):849-58. PubMed ID: 10072682
[TBL] [Abstract][Full Text] [Related]
18. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
19. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
[TBL] [Abstract][Full Text] [Related]
20. Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors.
Bender W; Staudt M; Tränkle C; Mohr K; Holzgrabe U
Life Sci; 2000 Mar; 66(18):1675-82. PubMed ID: 10809164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]